2015
New targets in breast cancer
Jhaveri A, Pusztai L. New targets in breast cancer. Memo - Magazine Of European Medical Oncology 2015, 8: 86-91. DOI: 10.1007/s12254-015-0197-5.Peer-Reviewed Original ResearchBreast cancerHuman epidermal growth factor receptor 2Epidermal growth factor receptor 2Novel clinical trial designsGrowth factor receptor 2Immune checkpoint modulatorsClinical trial designFactor receptor 2Akt/mammalian targetCyclin-dependent kinase 4/6Antibody-drug conjugatesPoly ADP-ribose polymeraseEndocrine therapyCheckpoint modulatorsADP-ribose polymeraseTherapeutic strategiesReceptor 2Trial designTherapeutic potentialMolecular abnormalitiesMammalian targetRapamycin (mTOR) pathwayNew drugsCancerNew targets
2011
The Value of Genomic Analysis of Breast Cancer in Drug Development
Szekely B, Pusztai L. The Value of Genomic Analysis of Breast Cancer in Drug Development. JNCI Monographs 2011, 2011: 60-62. PMID: 22043042, DOI: 10.1093/jncimonographs/lgr039.Peer-Reviewed Original Research